Nutrinia pulls in $30 mln Series D

Israel-based Nutrinia Ltd, an insulin developer for infants, has raised $30 million in Series D funding. TPG Biotech led the round with participation from other investors that included H.I.G. BioHealth Partners, WuXi Healthcare Ventures, OrbiMed and Pontifax. In conjunction with the funding, Dr. Eran Nadav, a partner and managing director at TPG Biotech and Aaron Davidson, co-head and managing director of H.I.G. BioHealth Partners, have been added to Nutrinia's board of directors.

North AmericaUSBriefs